Suppr超能文献

心房利钠肽与去脑大鼠交感和内分泌系统的相互作用。

Interactions of atrial natriuretic peptide with the sympathetic and endocrine systems in the pithed rat.

作者信息

Zukowska-Grojec Z, Haass M, Kopin I J, Zamir N

出版信息

J Pharmacol Exp Ther. 1986 Nov;239(2):480-7.

PMID:2877083
Abstract

We have found previously that atrial natriuretic peptides (ANPs) attenuate pressor response to alpha-2 adrenoceptor agonists but not to alpha-1 agonists in the pithed rat. We have now investigated the effects of ANP on other pressor agonists and on sympathetically mediated responses in rats. Bolus-injected ANP (0.1-10.0 nmol/kg) attenuated pressor responses to angiotensin II, vasopressin and alpha-2 adrenoceptor-mediated component of norepinephrine (NE)-induced responses (up to 17, 27 and 15%, respectively) in pithed rats. The threshold antipressor dose of ANP was the lowest for angiotensin II (comparable to normal levels of circulating ANP-immunoreactivity in rats) whereas it was higher for vasopressin and NE (comparable to plasma ANP-immunoreactivity stimulated by volume expansion). A 30-min infusion of ANP (0.15 nmol/kg/min) shifted the NE dose-pressor response curve 1.7-fold to the right. Conversely, neither that rate of ANP infusion nor the highest dose of bolus injected ANP altered pressor and plasma NE responses to sympathetic stimulation in demedullated pithed rats. However, at higher infusion rates, ANP reduced sympathetic stimulation-induced pressor responses (2.6-fold) and elevations of plasma NE levels (1.6-fold), without altering NE clearance. Similarly in conscious rats, ANP infusion prevented a reflex increase in plasma NE concentrations associated with hypotension. Thus, although the intrajunctional alpha-1 and presynaptic alpha-2 adrenoceptors are inaccessible to the short term bolus-induced elevation of circulating ANP during longer term increases in plasma ANP, it does reach the junction, reduces NE release and limits effects of receptor activation, possibly by diminishing Ca++ entry.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

我们先前发现,心房利钠肽(ANP)可减弱去脑大鼠对α-2肾上腺素能受体激动剂的升压反应,但对α-1激动剂无此作用。我们现在研究了ANP对大鼠其他升压激动剂以及交感神经介导反应的影响。静脉推注ANP(0.1 - 10.0 nmol/kg)可减弱去脑大鼠对血管紧张素II、血管加压素以及去甲肾上腺素(NE)诱导反应中α-2肾上腺素能受体介导成分的升压反应(分别高达17%、27%和15%)。ANP的最低抗升压剂量对于血管紧张素II来说是最低的(与大鼠循环中ANP免疫反应性的正常水平相当),而对于血管加压素和NE则较高(与容量扩张刺激的血浆ANP免疫反应性相当)。以0.15 nmol/kg/min的速度输注ANP 30分钟,使NE剂量 - 升压反应曲线右移1.7倍。相反,无论是该ANP输注速度还是静脉推注的最高剂量ANP,均未改变去髓质去脑大鼠对交感神经刺激的升压反应和血浆NE反应。然而,在较高输注速度下,ANP降低了交感神经刺激诱导的升压反应(2.6倍)以及血浆NE水平的升高(1.6倍),而未改变NE清除率。同样,在清醒大鼠中,输注ANP可防止与低血压相关的血浆NE浓度反射性升高。因此,尽管在血浆ANP长期升高期间,短期静脉推注诱导的循环ANP升高无法作用于接头内的α-1和突触前α-2肾上腺素能受体,但它确实能到达接头,减少NE释放并限制受体激活的影响,可能是通过减少Ca++内流实现的。(摘要截选至250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验